DEXCOM INC — Director's Dealing 2019

Jun 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2019-05-31

Reporting Person: Collins Richard Alexander (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-30	Common Stock	J	3449	—	Disposed	500	Direct
2019-05-31	Common Stock	A	2613	$0.001	Acquired	3113	Direct
2019-05-30	Common Stock	J	3449	—	Acquired	8804	Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units.

F2: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F3: Included in this number are 2,613 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

F4: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee.